Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07418502
PHASE2

Pressure Targeting During High Flow Therapy in Premature Infants

Sponsor: University of Texas at Austin

View on ClinicalTrials.gov

Summary

The goal of this study is to see if a new approach to breathing support ('Pressure Targeted High Flow') is as effective as standard of care ('Continuous Positive Airway Pressure') in prematurely born infants. It will also learn about the effect of these types of breathing support on infant comfort and impact on staffing. The main question it aims to answer is: Does Pressure Targeted High Flow provide enough support in premature infants? Participants will: Take spend 24 hours supported by Pressure Targeted High Flow and 24 hours supported by CPAP. During this time their breathing rate, oxygen requirement and other markers of comfort will be monitored.

Official title: A Phase 2 Crossover Trial of Pressure Targeted High Flow Therapy in Premature Infants

Key Details

Gender

All

Age Range

7 Days - 40 Weeks

Study Type

INTERVENTIONAL

Enrollment

78

Start Date

2026-05-01

Completion Date

2027-09

Last Updated

2026-02-18

Healthy Volunteers

No

Interventions

PROCEDURE

Pressure Targeted High Flow

High Flow Nasal Cannula therapy with Pressure monitoring to match delivered CPAP pressure

PROCEDURE

CPAP

Standard of care CPAP therapy

Locations (2)

Sharp Mary Birch Hospital for Women & Newborns

San Diego, California, United States

Ascension Seton Medical Center

Austin, Texas, United States